Is emcure an Indian company?
Is emcure an Indian company?
Emcure Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra.
Who owns Emcure Pharmaceuticals?
Satish Mehta
Pharma distributor’s son Satish Mehta founded and runs privately held generics maker Emcure Pharmaceuticals. He started Emcure in Pune city as a contract manufacturer for multinationals in 1981 then went on to sell his own branded generics. Private equity firm Bain Capital is a key investor in Emcure, with a 13% stake.
What is the brand name for cefuroxime axetil?
Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin antibiotic used to treat and prevent a number of bacterial infections. These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease.
Who manufactures cefuroxime?
Ranbaxy Laboratories Limited
6 /PRNewswire/ — Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Cefuroxime Axetil for Oral Suspension USP, 125 mg/5mL and 250 mg/5mL.
Has Ceftin been discontinued?
GlaxoSmithKline has made the decision to discontinue manufacturing Ceftin (cefuroxime axetil) Oral Suspension. The product discontinuation is not due to any quality, safety, or efficacy issues.
What class of drug is daonil?
Daonil belongs to a group of medicines called sulphonylureas. If your blood glucose is not properly controlled, you may experience hypoglycaemia (low blood glucose) or hyperglycaemia (high blood glucose).
Why ememcure pharmaceuticals?
Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lies in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood- related, oncology, respiratory, CNS & HIV among others.
What is the business model of Emcure?
We are a fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends an unparalleled competitive advantage establishing its presence in all major therapies in the domestic market.
Why Emcure for Women’s Health?
At Emcure, we believe that the success and growth of the company is in the hands of our people. Hence, we are committed towards nurturing talent and providing equal opportunities for their further development. Women’s Health continues to be a topic discussed in hushed tones with irrational stigmas and taboos associated with it.